CHRISTOPHER THIEL: Open Payments
NPI 1548906134 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 36 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $292 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $158 |
| Amgen Inc. | 4 | $67 |
| Novo Nordisk Inc | 3 | $58 |
| Lundbeck LLC | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
Products named: REXULTI, VRAYLAR, OTEZLA, MAVYRET, MOUNJARO, BREZTRI, Dexcom G6 Transmitter, Ozempic.
Industry payments across KS — which companies pay providers there.
